1. Panels
  2. Incidentalome_PREGEN_DRAFT
  3. TREM2
STRs in panel
Prev Next
Regions in panel
Prev Next

Incidentalome_PREGEN_DRAFT

Gene: TREM2

Amber List (moderate evidence)
TREM2 (triggering receptor expressed on myeloid cells 2)
EnsemblGeneIds (GRCh38): ENSG00000095970
EnsemblGeneIds (GRCh37): ENSG00000095970
OMIM: 605086, Gene2Phenotype
TREM2 is in 9 panels

1 review

Tony Roscioli (New South Wales Health Pathology)

Green List (high evidence)

Comment on list classification: Neurological symptoms appear not to present in childhood - needs review for a final decision
Created: 20 Jan 2021, 5:14 a.m. | Last Modified: 20 Jan 2021, 5:14 a.m.
Panel Version: 0.22
Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 2
onset after childhood for neurological and other symptoms
Created: 20 Jan 2021, 4:42 a.m. | Last Modified: 20 Jan 2021, 4:42 a.m.
Panel Version: 0.15
Created: 20 Jan 2021, 4:42 a.m.
Last Modified: 20 Jan 2021, 4:42 a.m.
Panel version: 0.15

History Filter Activity

20 Jan 2021, Gel status: 2

Entity classified by Genomics England curator

Tony Roscioli (New South Wales Health Pathology)

Gene: trem2 has been classified as Amber List (Moderate Evidence).

9 Nov 2020, Gel status: 3

Created, Added New Source, Set mode of inheritance

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

gene: TREM2 was added gene: TREM2 was added to Incidentalome_NSW. Sources: Expert Review Green,NSW Health Pathology Mode of inheritance for gene: TREM2 was set to Unknown